16,95 €
16,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
8 °P sammeln
16,95 €
16,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
8 °P sammeln
Als Download kaufen
16,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
8 °P sammeln
Jetzt verschenken
16,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
8 °P sammeln
  • Format: ePub

Amyotrophic lateral sclerosis, ALS, is a common form of motor neuron disease that involves a loss of function in upper and lower motor neurons. ALS causes a progressive loss of muscle function that frequently initiates in the limbs, called limb-onset ALS, or initiates in facial muscles, called bulbar-onset ALS. This book describes the current understanding of ALS symptoms, diagnosis, causes, and treatments. Initial symptoms vary in type of muscle dysfunction, intensity of symptoms, and speed of disease progression. Diagnosis requires loss of function in both upper and lower motor neurons for…mehr

  • Geräte: eReader
  • mit Kopierschutz
  • eBook Hilfe
  • Größe: 0.48MB
Produktbeschreibung
Amyotrophic lateral sclerosis, ALS, is a common form of motor neuron disease that involves a loss of function in upper and lower motor neurons. ALS causes a progressive loss of muscle function that frequently initiates in the limbs, called limb-onset ALS, or initiates in facial muscles, called bulbar-onset ALS. This book describes the current understanding of ALS symptoms, diagnosis, causes, and treatments. Initial symptoms vary in type of muscle dysfunction, intensity of symptoms, and speed of disease progression. Diagnosis requires loss of function in both upper and lower motor neurons for limb- and bulbar-onset ALS, distinguishing ALS from other neuromuscular diseases. Although no cause or initial trigger has been determined for ALS, eventually both limb and bulbar muscles will show dysfunction as the disease progresses. In later stages of the disease, muscle dysfunction typically leads to respiratory failure and death. Management of neurotransmitter levels in patients can prolong life by months, but no cure exits for the disease. Other treatments exist that can help patients manage muscle weakness or spasms as the disease progresses. The book concludes by considering future detection, treatment, and diagnostic approaches with the goal of preventing disease initiation or progression.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, D ausgeliefert werden.

Autorenporträt
Mary Elizabeth Miller is an associate professor and director of the biochemistry and molecular biology program at Rhodes College, TN. She holds the J. T. and V. B. Robertson Chair of Biological Sciences and has been awarded the Rhodes College Clarence Day Award for Outstanding Research or Creative Activity. She received her PhD in microbiology from the University of Virginia, Charlottesville VA, and studied as a post-doctoral fellow at the Rockefeller University, NY. Dr. Miller teaches introductory biology, genetics, molecular biology, microbiology, and topical seminars on cancer. She researches cell division and key regulators of cell division cycle.